Biota Holdings Articles
Biota and Nabi announce proposed merger
24 April 2012
Daiichi Sankyo launches flu drug Inavir inhaler in Japan; expands deal with ArQule; gets favorable patent ruling against Lupin
20 October 2010
Japanese regulator approves manufacture and marketing of Daiichi Sankyo/Biota’s flu drug Inavir
14 September 2010
Showing 1-4 of 4 articles
- 1
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
